Yıl: 2020 Cilt: 50 Sayı: 3 Sayfa Aralığı: 592 - 603 Metin Dili: İngilizce DOI: 10.3906/sag-2004-174 İndeks Tarihi: 24-04-2020

Novel coronavirus disease (COVID-19) in children

Öz:
Coronavirus disease (COVID-19) was firstly reported at the end of 2019. The disease rapidly spread all around the world in afew months and was declared a worldwide pandemic by WHO in March 2020. By April 9, there were 1,436,198 confirmed COVID-19cases in the world, nearly with 6% mortality rate. This novel infectious disease causes respiratory tract illness that may generally occur asmild upper respiratory tract disease or pneumonia. In older patients and/or patients with underlying conditions, it may result in acuterespiratory distress syndrome, multi organ failure and even death. According to the current literature, children account approximately for1%–5% of diagnosed COVID-19 cases. Generally, COVID-19 seems to be a less severe disease for children than adults. Approximately90% of pediatric patients are diagnosed as asymptomatic, mild, or moderate disease. However, up to 6.7% of cases may be severe. Severeillness is generally seen in patients smaller than 1 year of age and patients who have underlying disesases. The epidemiological andclinical patterns of COVID-19 and treatment approaches in pediatric patients still remain unclear although many pediatric reportsare published. This review aims to summarize the current epidemics, clinical presentations, diagnosis, and treatment of COVID-19 inpediatric patients.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Li Q, Guan X, Wu P, Wang X, Zhou L et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine 2020; 382 (13): 1199-1207. doi: 10.1056/NEJMoa2001316
  • 2. Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506. doi: 10.1016/S0140- 6736(20)30183-5.
  • 3. Dong Y, Mo X, Hu Y, Qi X, Jiang F et al. Epidemiology of COVID-19 among children In China. Pediatrics 2020. doi: 10.1542/peds.2020-0702
  • 4. Stoecklin BS, Rolland P, Silue Y, Mailles A, Campese C et al. Investigation Team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations, and control measures, January 2020. Eurosurveillance 2020; 25 (6): 2000094.
  • 5. Chan JF, Yuan S, Kok KH, To KK, Chu H et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395: 514-23. doi: 10.1093/infdis/jiaa077
  • 6. Chen Z, Fu J, Shu Q Chen Y, Hua C et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World Journal of Pediatrics (2020). doi: 10.1007/s12519-020-00345-5
  • 7. Zhu N, Zhang D, Wang W, Li X, Yang B et al. Coronavirus Investigating, and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. New England Journalof Medicine 2020. doi: 10.1056/NEJMoa2001017
  • 8. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. Features, Evaluation, and Treatment Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing; 2020 January-Last Update: March 20, 2020.
  • 9. Zhou P, Yang X, Wang X, Hu B, Zhang L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273. doi: 10.1038/s41586-020- 2012-7
  • 10. Chan JF, Kok KH, Zhu Z, Chu H, To KK et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes and Infections 2020; 9 (1): 221-236. doi: 10.1080/22221751.2020.1719902
  • 11. W. Li, M.J. Moore, N. Vasilieva, Sui J, Wong BK et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450-454. doi: 10.1038/nature02145
  • 12. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis 2020. doi: 10.1016/j.jpha.2020.03.001
  • 13. Xu Z, Shi L, Wang Y, Zhang J, Huang L et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine 2020; 8 (4): 420-422. doi: 10.1016/S2213-2600(20)30076-X
  • 14. Williams AE, Chambers RC, The mercurial nature of neutrophils: still an enigma in ARDS? American Journal of Physiology- Lung Cellular and Molecular Physiology 2014; 306 (3): 217-30. doi: 10.1152/ajplung.00311.2013
  • 15. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19? Journal of Microbiology Immunology and Infection 2020. doi: 10.1016/j. jmii.2020.02.011
  • 16. Han S, Mallampalli RK. The acute respiratory distress syndrome: from mechanism to translation. Journal of Microbiology Immunology and Infection. 2015; 194 (3): 855- 860. doi: 10.4049/jimmunol.1402513
  • 17. Xie X, Chen J, Wang X, Zhang F, Liu Y. Age- and gender-related difference of ACE2 expression in rat lung. Life Sciences 2006; 78: 2166-2171. doi:10.1016/j.lfs.2006.09.028
  • 18. Molloy EJ and Bearer CF. COVID-19 in children and altered inflammatory responses. Pediatric Research 2020. doi:10.1038/ s41390-020-0881-y
  • 19. Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology 2005; 16 (6): 791-801. doi:10.1097/01.ede.0000181633.80269.4c
  • 20. Ong SW, Tan YK, Chia PY, Lee TH, Ng OT et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 2020 . doi:10.1001/jama.2020.3227
  • 21. Xing YH, Ni W, Wu Q, Li WJ, Li GJ et al. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019. Journal of Microbiology Immunology and Infection 2020; 28: Pii: S1684-1182(20)30081-5. doi: 10.1016/j. jmii.2020.03.021
  • 22. Wang W, Xu Y, Gao R, Lu R, Han K et al. Detection of SARSCoV- 2 in different types of clinical specimens. JAMA 2020. doi: 10.1001/jama.2020.3786
  • 23. Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Archives of Pathology and Laboratory Medicine 2020. doi: 10.5858/arpa.2020-0901-SA
  • 24. Kimberlin DW, Stagno S. Can SARS-CoV-2 infection be acquired in utero?: more definitive evidence is needed. JAMA 2020. doi: 10.1001/jama.2020.4868
  • 25. Wang L, Shi Y, Xiao T, Fu J, Feng X et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (1st ed.). Annals of Translational Medicine 2020; 8 (3): 47. doi: 10.21037/atm.2020.02.20
  • 26. Chen H, Guo J, Wang C, Luo F, Yu X et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809-815. doi: 10.1016/S0140-6736(20)30360-3
  • 27. Davanzo R, Moro G, Sandri F, Agosti M, Moretti C et al. Breastfeeding and Coronavirus Disease-2019. Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies. Maternal and Child Nutrition 2020. doi: 10.1111/mcn.13010
  • 28. Kuiken T, Fouchier RAM, Schutten M, Rimmelzwaan GF, Van Amerongen G et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003; 362: 263-70. doi:10.1016/S0140-6736(03)13967-0
  • 29. Choi S, Kim HW, Kang J, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease 2019 in children. Korean Journal of Pediatrics 2020; 63 (4): 125-132. doi: 10.3345/cep.2020.00535
  • 30. Lu X, Zhang L, Du H, Zhang J, Li YY et al. SARSCoV- 2 infection in children 2020. New England Journal of Medicine 2000. doi: 10.1056/NEJMc2005073
  • 31. Cao O, Chen Y, Chen C, Chiu C.SARS-CoV-2 infection in children: transmission dynamics and clinical Characteristics. Journal of the Formosan Medical Association 2020; 119 (3): 670-673. doi: 10.1016/j.jfma.2020.02.009.
  • 32. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020. doi:10.1001/jama.2020.2648
  • 33. Zhang YP. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese Journal of Epidemiology 2020; 41: 145e51 (in Chinese). doi: 10.3760/cma.j.issn.0254-6450.2020.02.003
  • 34. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica 2020. doi: 10.1111/apa.15270
  • 35. Fang F, Zhao D, Chen Y et al. Recommendations for the diagnosis, prevention, and control of the 2019 novel coronavirus infection in children (first interim edition). Zhonghua Er Ke Za Zhi 2020; 145 (6): e20200834 (in Chinese). doi: 10.3760/ cma.j.issn.0578-1310.2020.0004
  • 36. Qiu H, Wu J, Hong L, Lo Y, Song Q et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet Infectious Diseases 2020. doi: 10.1016/S1473-3099(20)30198-5
  • 37. Cai J, Xu J, Lin D, Yang Z, Xu L et al. Author Notes. Clinical Infectious Diseases 2020. doi: 10.1093/cid/ciaa198
  • 38. Ji L, Chao S, Wang Y, Li X, Mu X et al. Clinical features of pediatric patients with COVID-19: a report of two family cluster cases. World Journal of Pediatrics 2020. doi:10.1007/ s12519-020-00356-2
  • 39. Wei M, Yuan J, Liu Y, Fu T, Yu X et al. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA 2020. doi:10.1001/jama.2020.2131
  • 40. Zeng L, Xia S, Yuan W, Yan K, Xiao F et al. Neonatal earlyonset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatrics 2020. doi:10.1001/jamapediatrics.2020.0878
  • 41. Zhu H, Wang L, Fang C, Peng S, Zhang L et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational Pediatrics 2020; 9 (1): 51-60. doi: 10.21037/ tp.2020.02.06
  • 42. Feng K, Yun YX, Wang XF, Yang GD, Zheng YJ et al. Analysis of CT features of 15 Children with 2019 novel coronavirus infection. Zhonghua Er Ke Zhi 2020 (in Chinese). doi: 10.3760/cma.j.issn.0578-1310.2020.0007
  • 43. Cheung J C-H Ho LT Cheng JV Cham EYK Lam KN. Staff safety during emergency airway management for COVID-19 in Hong Kong. The Lancet Respiratory Medicine 2020. doi: 10.1016/S2213-2600(20)30084-9
  • 44. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a Review. JAMA 2020. doi: 10.1001/ jama.2020.6019
  • 45. Yao X, Ye F, Zhang M, Cui C, Huang B et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical Infectious Disease 2020. doi: 10.1093/cid/ciaa237
  • 46. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends 2020; 14 (1): 72. doi: 10.5582/bst.2020.01047
  • 47. Karimi A, Tabatabaei SF, Rajabnejad M, Pourmoghaddas Z, Rahimi H. An algorithmic approach to diagnosis and treatment of coronavirus disease 2019 (COVID-19) in children: Iranian expert’s consensus statement. Archives of Pediatric Infectious Diseases 2020; 8 (2): e102400. doi: 10.5812/pedinfect.102400
  • 48. Gautret P, Lagier JC, Parola P, Hoan VT, Meddeb L et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents 2020. doi: 10.1016/j.ijantimicag.2020
  • 49. Molina JM, Delaugerre C, Goff JL, Mela-Lima B, Ponscarme D et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with Severe COVID-19 infection. Médicine et Maladies Infectieuses 2020. doi: 10.1016/j. medmal.2020.03.006
  • 50. Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T et al. Treatment and vaccines for severe acute respiratory syndrome. The Lancet Infectious Diseases 2005; 5 (3): 147-155. doi: 10.1016/S1473-3099(05)01307-1
  • 51. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine 2020.doi: 10.1056/NEJMoa2001282.
  • 52. Chan JF, Yao Y, Yeung ML, Deng W, Bao L et al. Treatment with lopinavir/ritonavir or interferon-β1 improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. Journal of Infectious Diseases 2015; 212: 1904-1913. doi: 10.1093/infdis/jiv392
  • 53. Wang M, Cao R, Zhang L, Yang X, Liu J et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research 2020; 30: 269. doi: 10.1038/s41422-020-0282-0
  • 54. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E et al. Compassionate use of remdesivir for patients with severe COVID-19. New England Journal of Medicine 2020. doi: 10.1056/NEJMoa2007016
  • 55. Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK et al. The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Critical Care 2016; 20: 75. doi: 10.1186/s13054- 016-1230-8
  • 56. Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020; 395 (10223): 497. doi: 10.1016/S0140- 6736(20)30183-5
  • 57. Hong X, Xiong J, Feng Z, Shi Y. Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19? International Journal of Infectious Diseases 2020. doi: 10.1016/j.ijid.2020.03.058
  • 58. Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. The Journal of Clinical Investigation 2020. doi: 10.1172/JCI138745
  • 59. Shen C, Wang Z, Zhao F, Yang Y, Li Jet al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 2020. doi: 10.1001/jama.2020.4783
  • 60. Cao W, Liu X, Bai T, Fan H, Hong Ket al. High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. Open Forum Infectious Diseases 2020; 7 (3). doi: 10.1093/ofid/ofaa102
APA TEZER H, Bedir Demirdag T (2020). Novel coronavirus disease (COVID-19) in children. , 592 - 603. 10.3906/sag-2004-174
Chicago TEZER HASAN,Bedir Demirdag Tugba Novel coronavirus disease (COVID-19) in children. (2020): 592 - 603. 10.3906/sag-2004-174
MLA TEZER HASAN,Bedir Demirdag Tugba Novel coronavirus disease (COVID-19) in children. , 2020, ss.592 - 603. 10.3906/sag-2004-174
AMA TEZER H,Bedir Demirdag T Novel coronavirus disease (COVID-19) in children. . 2020; 592 - 603. 10.3906/sag-2004-174
Vancouver TEZER H,Bedir Demirdag T Novel coronavirus disease (COVID-19) in children. . 2020; 592 - 603. 10.3906/sag-2004-174
IEEE TEZER H,Bedir Demirdag T "Novel coronavirus disease (COVID-19) in children." , ss.592 - 603, 2020. 10.3906/sag-2004-174
ISNAD TEZER, HASAN - Bedir Demirdag, Tugba. "Novel coronavirus disease (COVID-19) in children". (2020), 592-603. https://doi.org/10.3906/sag-2004-174
APA TEZER H, Bedir Demirdag T (2020). Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences, 50(3), 592 - 603. 10.3906/sag-2004-174
Chicago TEZER HASAN,Bedir Demirdag Tugba Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences 50, no.3 (2020): 592 - 603. 10.3906/sag-2004-174
MLA TEZER HASAN,Bedir Demirdag Tugba Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences, vol.50, no.3, 2020, ss.592 - 603. 10.3906/sag-2004-174
AMA TEZER H,Bedir Demirdag T Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences. 2020; 50(3): 592 - 603. 10.3906/sag-2004-174
Vancouver TEZER H,Bedir Demirdag T Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences. 2020; 50(3): 592 - 603. 10.3906/sag-2004-174
IEEE TEZER H,Bedir Demirdag T "Novel coronavirus disease (COVID-19) in children." Turkish Journal of Medical Sciences, 50, ss.592 - 603, 2020. 10.3906/sag-2004-174
ISNAD TEZER, HASAN - Bedir Demirdag, Tugba. "Novel coronavirus disease (COVID-19) in children". Turkish Journal of Medical Sciences 50/3 (2020), 592-603. https://doi.org/10.3906/sag-2004-174